erenumab (aimovig) is the first of four new migraine drugs in the pipeline that target calcitonin gene-related peptide (cgrp), a molecule that's produced in nerve cells of the .
shocking figures uncovered by labour show some patients are suffering agonising waits of as many as 541 days to begin treatment
.
cnn sans ™ & © 2016 cable news network.
http://lm360.us/Killeen-sister-of-Manalo-from-Cerain?Chappelear=143
"we were quite surprised to find there were no significant differences," says study author
.
.